| __timestamp | Vertex Pharmaceuticals Incorporated | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 305409000 | 7751000 |
| Thursday, January 1, 2015 | 377080000 | 10251000 |
| Friday, January 1, 2016 | 432829000 | 9575000 |
| Sunday, January 1, 2017 | 496079000 | 10912000 |
| Monday, January 1, 2018 | 557616000 | 11049000 |
| Tuesday, January 1, 2019 | 658498000 | 11646000 |
| Wednesday, January 1, 2020 | 770456000 | 13265000 |
| Friday, January 1, 2021 | 840100000 | 25805000 |
| Saturday, January 1, 2022 | 944700000 | 35182000 |
| Sunday, January 1, 2023 | 1136600000 | 94999000 |
| Monday, January 1, 2024 | 1464300000 |
Data in motion
In the competitive world of biotechnology, managing costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Vertex Pharmaceuticals Incorporated and Viridian Therapeutics, Inc. from 2014 to 2023. Vertex Pharmaceuticals, a leader in the industry, has seen its SG&A expenses grow by approximately 272% over this period, reflecting its expanding operations and market reach. In contrast, Viridian Therapeutics, a smaller player, has experienced a staggering increase of over 1,125% in SG&A expenses, indicating rapid growth and investment in its business infrastructure.
This data highlights the dynamic nature of the biotech sector, where strategic spending can drive innovation and market leadership.
Novo Nordisk A/S vs Viridian Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Johnson & Johnson vs Viridian Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Incyte Corporation
Vertex Pharmaceuticals Incorporated and Bio-Techne Corporation: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or Alpine Immune Sciences, Inc.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.
Operational Costs Compared: SG&A Analysis of Vertex Pharmaceuticals Incorporated and MorphoSys AG
Breaking Down SG&A Expenses: Vertex Pharmaceuticals Incorporated vs MannKind Corporation
Breaking Down SG&A Expenses: GSK plc vs Viridian Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of argenx SE and Viridian Therapeutics, Inc.
Halozyme Therapeutics, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?